Table 3.

Subjective evaluation by surgeon and observer of ICG-FI in time to visibility (TTV), time to maximum visibility (TMV) and time to wash-out (TWO) from the two different ICG dosages

Dose of ICG	Primary surgeon			Observer
	7.5 mg	15 mg	p-value	7.5 mg	15 mg	p-value
TTV	32 (26–38)	33 (26–40)	0.71	29 (23–34)	40 (30–39)	0.08
TMV	51 (42–59)	57 (45–69)	0.44	51 (54–78)	66 (54–78)	0.11
TWO	70 (59–81)	82 (69–95)	0.2	69 (57–82)	85 (72–98)	0.09

Values are mean 95% confidence limits in brackets